2025-2034 Cell & Gene Therapy Manufacturing Services Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cell & Gene Therapy Manufacturing Services Market Through 2025?
The market size for cell & gene therapy manufacturing services has seen a significant increase in recent times. The market value is projected to rise from $8.15 billion in 2024 to $9.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.1%. This growth during the historic period is linked to factors such as enhanced R&D expenditures, supportive regulatory frameworks, an expanding pipeline for cell & gene therapies, as well as industry collaborations and partnerships. There's also an increase in the worldwide demand for personalized medicine.

What's the Projected Size of the Global Cell & Gene Therapy Manufacturing Services Market by 2029?
In the coming years, the manufacturing services market for cell and gene therapy is poised for fast-paced expansion. The projected growth rate is at a Compound Annual Growth Rate (CAGR) of 17.4%, ultimately reaching $17.97 billion by 2029. This forthcoming growth can be tied to several factors such as the market maturation and commercialization, the global expansion of biopharmaceutical production, increasing outsourcing by pharmaceutical firms, as well as advances in automation and robotics, and the introduction of new therapeutic modalities. Key future trends within this period include an increase in demand for energy efficiency, advanced materials and technologies, compact and modular designs, the electrification of transportation, as well as an emphasis on safety and reliability.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

Top Growth Drivers in the Cell & Gene Therapy Manufacturing Services Industry: What's Accelerating the Market?
The increase in cases of cancer and other targeted diseases is projected to boost the expansion of the cell and gene therapy manufacturing services market. Cancer, a grave illness characterized by the rapid and unregulated multiplication of body cells resulting in abnormal growths, is on the increase. To tackle this rise, cell and gene therapies are emerging as potential new methodologies, thus pushing the needs for new and effective treatment modalities. For instance, the American Cancer Society, a non-profit cancer advocacy organization based in the US, indicates an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in January 2023, a growth of about 3.16%. Consequently, the escalating cases of cancer and other diseases targeted for these therapies are propelling the cell and gene therapy manufacturing services market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

What Trends Will Shape the Cell & Gene Therapy Manufacturing Services Market Through 2029 and Beyond?
Rapid progression in technology is a prominent trend in the cell and gene therapy manufacturing services market that is gaining increasing recognition. To maintain their competitive edge, leading companies in this sector are harnessing new technologies. For example, in October 2022, Charles River Laboratories International Inc., an American pharma firm specialized in a myriad of preclinical and clinical laboratory, gene therapy, and cell therapy services, rolled out their navigation Vector Platform (navigation). This platform provides a simplified route towards GMP Adeno-Associated Virus (AAV) vector manufacturing, eliminating the need for extensive process development. The navigation platform has shown its efficiency by reducing the transition time to GMP for viral vector gene therapy researchers by 55% compared to conventional manufacturing procedures. Charles River leverages their unique high-yield HEK293 suspension cell line in this navigation process, which can be scaled up and serotyped according to client demands.

What Are the Main Segments in the Cell & Gene Therapy Manufacturing Services Market?
The cell & gene therapy manufacturing services market covered in this report is segmented -

1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp

Which Top Companies are Driving Growth in the Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

Which Regions Will Dominate the Cell & Gene Therapy Manufacturing Services Market Through 2029?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.